Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial

BACKGROUND: The WHO ACTION-I trial demonstrated that dexamethasone significantly reduced neonatal mortality when administered to women at risk of early preterm birth in low-resource countries. We conducted a secondary analysis to determine how these benefits can be optimised, by evaluating the effec...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716334/
https://www.ncbi.nlm.nih.gov/pubmed/36467459
http://dx.doi.org/10.1016/j.eclinm.2022.101744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716334/
https://www.ncbi.nlm.nih.gov/pubmed/36467459
http://dx.doi.org/10.1016/j.eclinm.2022.101744

Ejemplares similares